Safety and Effectiveness of Siddha Sastric Medicines for the Management of Covid-19

Phase 2

• Conditions: Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

• Registration Number: CTRI/2020/07/026470
• Lead Sponsor: Almaa Siddha Multispeciality Hospital Pvt Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. COVID -19 Positive as determined by RT-PCR or other approved commercial or public health assay

2. Willing to provide written/digital informed consent.

3.COVID - 19 Positive with no clinical signs

4.COVID - 19 Positive with mild symptoms â?? Sneezing, Cough, Sore Throat, Throat Pain, Malaise, Tiredness, Fever

5.COVID - 19 Positive with moderate symptoms â?? Fever with cough, breathlessness but respiratory rate <24 per minute and Oxygen saturation more than 94% at rest

Exclusion Criteria

1. Pregnant and Lactating females

2. COVID - 19 Positive with Severe symptoms â?? Respiratory distress ( >24 breath per minute), Oxygen saturation less than 94% at rest, Respiratory failure, Need of Mechanical Ventilation, Septic shock, Non respiratory organ failure

3. Chronic Renal Failure requiring dialysis (eGFR < 30)

4. Known cases of uncontrolled Diabetes ( >9% HbA1c)

5. Subjects having any medical or surgical condition that would require immediate medical or surgical intervention at the time of screening

6. Subjects having immune compromised status like HIV, Hepatitis, Tuberculosis, Cancer etc.

7. Subjects taking Steroid treatment and or any kind of immunosuppressive therapy

8. Subjects participating in any other clinical study or having participated in any other study 1 month prior to screening in the present study.

9. Subjects having a past history of allergy to any medicine that is part of the Siddha intervention.

10. Subjects with bleeding disorders and severe anaemia(Hb - <7 g/dL)

Study & Design

• Study Type: Interventional
• Study Design: Not specified